Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-alpha4/beta7 [A4B7R1]

Anti-alpha4/beta7 [A4B7R1]
Product Type: Blocking Antibodies (Receptor-Ligand Antagonists)
Format: Anti-alpha-4/beta-7 integrin, humanized variable region, rhesus IgG1LAGA Fc
Clone ID: [A4B7R1]
RRID: AB_2716326
Common Names: Anti-alpha4/beta7 [A4B7R1] | Anti-alpha-4/beta-7 integrin | pACT1 | vedolizumab | Anti-Alpha-4/beta-7 | PR-1427 | NHP16
Target: Alpha4/beta7
Reactivity: Rhesus Macaque (Macaca mulatta) Human (Homo sapiens)
Applications: in vivo
Description:

A4B7R1LAGA: Rhesus recombinant, humanized anti-alpha4beta7, effector-silenced IgG1-kappa antibody. Derived from vedolizumab.

 
Modifications: None
Restrictions: No
Sponsor: NIAID
How to cite (Methods): Anti-alpha4/beta7 [A4B7R1] (NHPRR Cat#PR-1427, RRID:AB_2716326)
How to cite (Acknowledgments): The Anti-alpha4/beta7 [A4B7R1] antibody (Cat#PR-1427, RRID:AB_2716326) used in this study was provided by the Nonhuman Primate Reagent Resource (NHPRR, RRID:SCR_012986), funded by NIAID U24 AI126683.

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025